Personalized Antiplatelet Secondary Stroke PRevenTion
NCT03979781
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Ischemic Stroke
TIA
Interventions
DRUG:
tailored antiplatelet selection
DRUG:
standard of care
Sponsor
State University of New York - Upstate Medical University